CRC 001

A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Assess the Efficacy and Safety of Baxdrostat in Participants with Uncontrolled Hypertension on Two or More Medications including Participants with Resistant Hypertension
18 + / / Earn up to $1,615

About the Study

A Randomised, Double-Blind, Placebo-Controlled, Parallel Group Study to Assess the Efficacy and Safety of Baxdrostat in Participants with Uncontrolled Hypertension on Two or More Medications including Participants with Resistant Hypertension. We are doing this study to learn more about an investigational drug called Baxdrostat for treating high blood pressure that is not responding well enough to current treatment.

We are doing this study to learn more about an investigational drug called Baxdrostat for treating high blood pressure that is not responding well enough to current treatment. Hypertension is a serious condition that can cause several complications and may reduce your life expectancy if not treated appropriately. Baxdrostat has already been tested in participants with difficult-to-control high blood pressure in earlier research called “Phase 2” studies. Based on what we have learned in those studies about the potential for Baxdrostat to improve blood pressure levels, this Phase 3 study has been developed.

Qualifications

Are you on two or more medications to treat hypertension?

Is one of your hypertension medications a diuretic (water pill)?

By submitting this form, you consent to receive communications via text message and email from JCCT. Your contact information will remain confidential, but may be used to send you updates, appointment data and other relevant information. You can unsubscribe from these communications at any time by following the instructions included in each message.

Would you like to receive personalized alerts for all future opportunities – click below to join our mailing list.

Join our mailing list

Frequently asked questions

View all FAQs

What is a screening visit?

A screening visit is your first visit to our facility and takes roughly 2-4 hours. After filling out paperwork and reviewing a consent form, one of our nurses will go over the details to ensure your understanding.
This is the perfect time to ask any questions about the study and how your participation will affect you.
The nurse will then go over your medical history and take vitals.
The next step is completing a physical with our doctor. If our doctor deems you healthy enough for the study, you will then see our phlebotomist for a blood draw.

How do I prepare for my screening visit?

The night before:

  • Hydrate, hydrate, hydrate!
  • Avoid a large consumption of alcohol
  • Avoid sugary foods and drinks

The morning of:

  • Continue to hydrate well
  • Eat a light, healthy breakfast (Examples: bagels, scrambled eggs, yogurt, fruit, whole grain cereal)
  • Bring a photo ID
  • Make sure you have a form of entertainment (Examples: Books, magazines, mobile video game systems, laptops, etc.)

What questions should I ask the nurse?

First, you can ask our nurses any questions that come to your mind at any point of the process. But some good examples are:

  • Has this new medication/vaccine been tested on humans before?
  • What is the purpose of this new medication/vaccination?
  • What are the risks involved?
  • What company developed the medication/vaccine?
  • What is the procedure?
  • How/What samples are collected?
  • How long is the trial?

What is informed consent?

Informed consent is the process of our volunteers being given all the information about the study. For your protection, all clinical trial facilities MUST give you all the details (including risks and benefits) pertaining to the study before you give consent to volunteer. All volunteers must sign the informed consent before they can participate in a trial. As the study progresses, there could be additional informed consent forms that require your signature.

JCCT takes this process very seriously. You will be given 1 on 1 time with one of our nurses to go over the consent form and ask as many questions as you need before you sign.